NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only


NSABP Foundation, Inc.



General NSABP Information
  Financial Conflicts of
     Interest Policy
  Coalition Comment:
     Reconfiguration
  IOM Report Group Comment
  Contact the NSABP
  Pathology Section
  Future Meetings
  NSABP Newsletters
  Media Info on STAR
  Employment

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-43
  Protocol B-47
  Protocol B-51

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR
  Protocol P-5
  BreastCancerPrevention.com

Scientific Publications

Related Web Sites



Medical Search Engines



To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu

Annotated Bibliography of NSABP Publications


Validation of a Self-Reported Neurotoxicity Scale in Patients With Operable Colon Cancer Receiving Oxaliplatin.
Kopec JA, Land SR, Cecchini RS, Ganz PA, Cella D, Costantino JP, Wieand HS, Smith RE, Kuebler JP, Wolmark N.
J Supp Oncol. 2006;4(8):W1-W8. [Epub only]

Abstract
Standardized questionnaires are important tools for evaluating adverse effects associated with new cancer treatments. This randomized trial, which assessed the measurement properties of the modifed Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale, was conducted in a subsample of patients participating in the National Surgical Adjuvant Breast and Bowel Project Protocol C-07.